MARKET

CDXS

CDXS

Codexis Inc
NASDAQ
2.820
-0.060
-2.08%
After Hours: 2.830 +0.01 +0.35% 19:21 07/18 EDT
OPEN
2.930
PREV CLOSE
2.880
HIGH
2.963
LOW
2.810
VOLUME
617.70K
TURNOVER
--
52 WEEK HIGH
6.08
52 WEEK LOW
1.900
MARKET CAP
233.62M
P/E (TTM)
-2.8534
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CDXS last week (0707-0711)?
Weekly Report · 5d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 07/10 21:05
Weekly Report: what happened at CDXS last week (0630-0704)?
Weekly Report · 07/07 09:17
What You Can Learn From Codexis, Inc.'s (NASDAQ:CDXS) P/S
Simply Wall St · 07/03 10:36
Major Shareholder Makes Bold Move with Codexis Stock Purchase
TipRanks · 07/02 02:04
Weekly Report: what happened at CDXS last week (0623-0627)?
Weekly Report · 06/30 09:18
Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Perspective Therapeutics (CATX) and Codexis (CDXS)
TipRanks · 06/23 12:40
Weekly Report: what happened at CDXS last week (0616-0620)?
Weekly Report · 06/23 09:17
More
About CDXS
Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.

Webull offers Codexis Inc stock information, including NASDAQ: CDXS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDXS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDXS stock methods without spending real money on the virtual paper trading platform.